Navigation Links
Non-Invasive Radiosurgery with Novalis Tx(TM) Platform Rolling Out Worldwide
Date:9/22/2008

Powerful technology from Varian Medical Systems and BrainLAB enabling non-invasive treatment of cancer and disorders of the central nervous

system

PALO ALTO, Calif., and WESTCHESTER, Ill., Sept. 22 /PRNewswire-FirstCall/ -- Doctors around the globe are turning more and more to the use of stereotactic body radiosurgery (SBRT) for the treatment of cancer and other conditions. Using the Novalis Tx platform from Varian Medical Systems (NYSE: VAR) and BrainLAB, doctors are performing image-guided radiosurgery to treat tumors of the brain, spine, lung, and liver, without a single incision in the patient. This advanced technology is on display this week at both the 50th annual meeting of the American Society for Therapeutic Radiology and Oncology in Boston, and at the Congress of Neurological Surgeons 2008 meeting in Orlando, Florida.

"Novalis Tx is a very versatile machine that will facilitate image-guided treatment for a variety of body sites," says Naren Ramakrishna, MD, PhD, Chief, CNS (Central Nervous System) radiation oncology, Brigham and Women's/Dana Farber. "Combining the advanced technologies for imaging, treatment planning, and treatment delivery from both companies, it offers clinicians a fast, versatile, highly precise radiosurgery device for image-guided treatments of the brain or body."

Novalis Tx enables doctors to deliver fast radiosurgery treatments for a large number of indications, including malignant and benign lesions, brain metastases, arteriovenous malformations, and functional lesions. Designed for fast, precise, noninvasive radiosurgical procedures, the Novalis Tx has been adopted by leading academic institutions, regional medical centers, and community hospital
'/>"/>

SOURCE Varian Medical Systems, Inc.; BrainLAB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level
2. InSightec Resumes Clinical Trials for Non-Invasive Treatment of Brain Tumors
3. Cheetah Medicals NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting
4. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
5. CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide
6. Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery
7. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
8. Angiotech announces commercial launch of Cook Medicals Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
9. eGenomics Awarded First U.S. Patent Covering Rapid DNA Sequencing Technology Platform to Control Hospital-Acquired Infections
10. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
11. BioNanomatrix Awarded New NIH Grant for Development of Nanoscale Platform for Single-Molecule DNA Mapping and Haplotype Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... OSAKA, Japan , April 16, 2015 ... of Kyoto University and Takeda Pharmaceutical Company Limited ... to develop clinical applications of induced pluripotent stem ... mellitus, neurological disorders and cancer immunotherapy. The "Takeda-CiRA ... designed to expedite multiple research projects for drug ...
(Date:4/16/2015)... 16, 2015 Proove Biosciences , ... of BIO Contest for the 2015 BIO International ... 2015 BIO International Convention will take place June 15-18 ... the Buzz of BIO contest, industry leaders will be ... at the conference. The community voting period began on ...
(Date:4/16/2015)... OncoTAb, Inc., a University ... company, announced today the appointment of physician and ... Operating Officer (COO). Cooper brings to OncoTAb more ... diagnostic and biotechnology platforms in the fields of ... career transcends the field of medical and scientific ...
(Date:4/16/2015)... , April 16, 2015  RegeneRx Biopharmaceuticals, Inc. ... its U.S. joint venture with G-treeBNT (ReGenTree LLC) ... 3 clinical trial for the orphan disorder, neurotrophic ... for dry eye syndrome (DES) in the U.S.  ... drops, RGN-259/GBT201, this year.  Each of these eye ...
Breaking Biology Technology:CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 2CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 3Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 2Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 3OncoTAb Names Dr. David L. Cooper as COO 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5
... Dec. 15, 2011  Sequenom, Inc. (NASDAQ: SQNM ), ... announced that the company has been upgraded to the NASDAQ ... with the highest initial listing standards of any exchange in ... under the ticker symbol, "SQNM," and will transfer its stock ...
... Genetics Policy Institute (GPI) announced today that the ... scheduled for Dec. 3-5, 2012 at the Palm Beach ... (Logo: http://photos.prnewswire.com/prnh/20111214/DC23304LOGO ) Genetics ... of Miami Miller School of Medicine and the Diabetes ...
... Therapeutics (Euronext: AMT), a leader in the field of human ... equity position, as a result of ongoing loss-making operations. The ... previous guidance that the Company has cash into early 2012, ... announced on November 17, 2011 that its cash position at ...
Cached Biology Technology:Sequenom Named to NASDAQ Global Select Market 2Sequenom Named to NASDAQ Global Select Market 3West Palm Beach, FL to Host 8th Annual World Stem Cell Summit December 3-5, 2012 2West Palm Beach, FL to Host 8th Annual World Stem Cell Summit December 3-5, 2012 3Amsterdam Molecular Therapeutics Announces Negative Equity Position 2Amsterdam Molecular Therapeutics Announces Negative Equity Position 3
(Date:4/2/2015)... -- Fingerprint Cards (FPC) has received an ... distributor World Peace Industrial Group (WPI), part of WPG ... major part of the shipments will take place during ... manufacturers in China . The order ... revenue guidance of + 1 000 MSEK for 2015.  ...
(Date:3/31/2015)... --  Guidepoint , a leading global research services firm, ... TRACKER, part of the Guidepoint TRACKER suite ... device and therapeutics markets. The Post-Surgical Pain Management TRACKER ... share, and adoption rates across three major modalities used ... The Post-Surgical Pain Management TRACKER will provide length ...
(Date:3/24/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) has ... Global Strategic Business Report" report to their offering. ... in US$ Thousands by the following Segments: Face Biometrics, and Voice ... Canada , Japan , ... East & Africa , and ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
... scientists studying the reliability of species distribution models ... change have focused their research on the endangered ... Ecography demonstrates that studying weather events, ... offers a clearer insight into the Bettong,s movements, ...
... In the central Arctic the proportion of old, thick sea ... consists of thin, one-year-old floes. This is one of the ... and Marine Research in the Helmholtz Association brought back from ... The ship arrived at its home port of Bremerhaven at ...
... [Brown University] Given the stakes of in vitro fertilization, ... can get about the eggs they will extract, attempt to ... & Infants Hospital of Rhode Island has found a way ... harming it. As researchers learn more about how those genes ...
Cached Biology News:Australia's endangered bettong reveals how weather effects species distribution 2Young and thin instead of old and bulky 2Young and thin instead of old and bulky 3Young and thin instead of old and bulky 4'Genetic biopsy' of human eggs might help pick the best for IVF 2'Genetic biopsy' of human eggs might help pick the best for IVF 3
... in DMEM and harvested at the log phase ... antigens in their native forms, cells were fixed ... a 12-well (5 mm) adhesive coated slide, with ... attachment and to minimize background staining. Each ...
... Pre-tested for optimal ... support the growth of ... for methylcellulose colony-forming assays ... hematopoietic cells. Not suitable ...
... RNA Sample Buffer is a ... for experimental samples and Perfect ... buffer needs no dilution and ... denaturing gels. Simply mix equal ...
... assay for mitochondrial membrane potential detection ... are detected by carboxyfluorescein (FAM)-labelled fluoromethylketone ... non-cytotoxic and bind covalently to the ... the same time the mitochondrial membrane ...
Biology Products: